First Time Loading...

Psychemedics Corp
NASDAQ:PMD

Watchlist Manager
Psychemedics Corp Logo
Psychemedics Corp
NASDAQ:PMD
Watchlist
Price: 2.53 USD -0.39% Market Closed
Updated: May 8, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

12.3m
-13%
Assets
Growth Rates:
1 Year
-34%
3 Years
-49%
5 Years
-51%
7 Years
-51%
10 Years
-26%
5.7m
-15%
Liabilities
Growth Rates:
1 Year
-29%
3 Years
-51%
5 Years
-9%
7 Years
-40%
10 Years
+32%
6.7m
-10%
Equity
Growth Rates:
1 Year
-38%
3 Years
-47%
5 Years
-64%
7 Years
-57%
10 Years
-46%

Balance Sheet Decomposition
Psychemedics Corp

12.3m
Assets
5.7m
Liabilities
12.3m
Assets
5.7m
Liabilities
Current Assets 6.8m
Cash & Short-Term Investments 2m
Receivables 3.7m
Other Current Assets 1.1m
Non-Current Assets 5.5m
PP&E 4.9m
Other Non-Current Assets 632k
Current Liabilities 4.7m
Accounts Payable 752k
Accrued Liabilities 3.7m
Other Current Liabilities 305k
Non-Current Liabilities 945k
Other Non-Current Liabilities 945k

Balance Sheet
Psychemedics Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
4
3
4
8
4
7
3
2
5
2
Cash Equivalents
4
3
4
8
4
7
3
2
5
2
Short-Term Investments
0
0
0
0
4
0
0
0
0
0
Total Receivables
6
4
6
4
5
4
6
7
4
4
Accounts Receivables
4
4
6
4
5
4
3
4
4
4
Other Receivables
2
1
0
0
0
0
2
3
0
0
Other Current Assets
1
1
1
1
1
2
1
2
1
1
Total Current Assets
11
8
11
14
14
13
10
10
10
7
PP&E Net
13
13
13
12
10
14
14
10
7
5
PP&E Gross
13
13
13
12
10
14
14
10
7
5
Accumulated Depreciation
6
7
9
12
13
16
17
20
22
24
Intangible Assets
1
1
1
1
1
1
1
1
1
1
Other Long-Term Assets
0
0
0
0
0
0
0
0
1
0
Total Assets
24
N/A
22
-8%
25
+14%
27
+6%
25
-6%
28
+10%
24
-13%
22
-10%
19
-13%
12
-34%
Liabilities
Accounts Payable
1
1
1
0
1
1
1
1
0
1
Accrued Liabilities
1
1
2
2
2
4
3
4
4
4
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
2
1
1
0
1
1
1
0
0
Other Current Liabilities
0
0
0
1
1
1
0
0
1
0
Total Current Liabilities
4
4
5
4
4
6
4
6
6
5
Long-Term Debt
5
4
2
2
1
2
3
1
0
0
Deferred Income Tax
3
3
3
1
1
1
0
0
0
0
Other Liabilities
0
0
0
0
0
2
4
3
2
1
Total Liabilities
11
N/A
10
-8%
9
-9%
8
-16%
6
-21%
11
+72%
11
+7%
9
-19%
8
-15%
6
-29%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
7
8
5
2
1
4
9
10
12
17
Additional Paid In Capital
29
30
31
31
32
32
33
33
34
35
Treasury Stock
10
10
10
10
10
10
10
10
10
10
Other Equity
0
0
0
0
1
2
2
2
2
2
Total Equity
13
N/A
12
-9%
16
+34%
19
+19%
19
+1%
17
-10%
13
-26%
12
-2%
11
-12%
7
-38%
Total Liabilities & Equity
24
N/A
22
-8%
25
+14%
27
+6%
25
-6%
28
+10%
24
-13%
22
-10%
19
-13%
12
-34%
Shares Outstanding
Common Shares Outstanding
5
5
5
5
6
6
6
6
6
6

See Also

Summary
PMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
PMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PMD stock valuation using valuation multiples.
Wall Street Estimates
PMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.